Adial Pharmaceuticals, Inc. Finance Lease, Liability, Current
Adial Pharmaceuticals, Inc. (ADIL) had Finance Lease, Liability, Current of $58.75 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:FinanceLeaseLiabilityCurrent · last filed 2023-05-12
- 2023-03-31: Finance Lease, Liability, Current $58.75K.
- 2022-12-31: Finance Lease, Liability, Current $56.83K.
- 2022-09-30: Finance Lease, Liability, Current $54.96K.
- 2022-06-30: Finance Lease, Liability, Current $53.14K.
| Period end | Finance Lease, Liability, Current |
|---|---|
| 2023-03-31 | $58.75K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $56.83K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $54.96K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $53.14K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $51.35K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $49.59K 10-K · filed 2023-03-30 |
| 2021-09-30 | $47.82K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $46.09K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $44.40K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |